Substance-K receptor — Drug Target

All drugs that target Substance-K receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Vinca Alkaloid

Marketed (1)

• Navelbine · Pierre Fabre · Vinca Alkaloid · Oncology
  Navelbine works by binding to the Substance-K receptor, disrupting microtubule formation and inhibiting cell division.